LCID
Lucid Group, Inc.
LCID has the edge over PRKS overall, supported by stronger fundamentals and stronger modeled upside.
PRKS
United Parks & Resorts Inc.
PRKS has lower modeled downside risk, despite its lower overall score.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
PRKS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Weak |
PRKS's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is weak.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
PRKS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 11x | $40.16 | — |
| Cheap | 12x | $32.45 | -19% |
| Fair | 14x | $37.08 | -7.7% |
| Current | 15x | $40.16 | — |
| Expensive | 18x | $47.84 | +19% |
Historical ranges are pointers, not guarantees.
PRKS's PE is in its expensive range at 15x. On analysts' estimates for next year's earnings, today's price would be 11x, in its cheap range.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
PRKS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Stable | |
| Stable | |
| Weakening | |
| Limited | |
| Low |
Analysts expect PRKS's profitability to weaken, with its earnings and revenue holding steady. However, they disagree widely on these estimates.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
PRKS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.65 | +36% |
| Q3 2026 | $2.68 | -16% |
| Q2 2026 | $2.55 | -30% |
| Q1 2026 | $2.66 | -28% |
| Q4 2025 | $3.06 | -19% |
| Q3 2025 | $3.19 | -20% |
| Q2 2025 | $3.66 | -4.4% |
| Q1 2025 | $3.67 | -1.3% |
| Q4 2024 | $3.79 | +4.4% |
PRKS has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over PRKS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
PRKS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $506.5M | -1.1% |
| Q2 2026 | $483.3M | -1.4% |
| Q1 2026 | $278.3M | -3% |
| Q4 2025 | $373.5M | -2.8% |
| Q3 2025 | $511.9M | -6.2% |
| Q2 2025 | $490.2M | -1.5% |
| Q1 2025 | $286.9M | -3.5% |
| Q4 2024 | $384.4M | -1.2% |
PRKS's revenue grew through 2022 and has held roughly level since: $506M last quarter, down 1.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 28% | -1.9 points |
| Q2 2026 | 24% | -4.4 points |
| Q1 2026 | -3% | -8.9 points |
| Q4 2025 | 15% | -4.6 points |
| Q3 2025 | 30% | -7.2 points |
| Q2 2025 | 29% | -4.4 points |
| Q1 2025 | 5.9% | -1.6 points |
| Q4 2024 | 20% | -3.2 points |
PRKS has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
PRKS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $23.5M | -38% |
| Q2 2026 | $101.5M | -21% |
| Q1 2026 | -$2.8M | +$28.4M |
| Q4 2025 | $28.1M | -67% |
| Q3 2025 | $38M | -44% |
| Q2 2025 | $127.6M | +36% |
| Q1 2025 | -$31.2M | -$15.3M |
| Q4 2024 | $86.2M | +141% |
PRKS has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
PRKS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.5% | -1.2M shares |
| 1 year | -17% | -9.5M shares |
| 3 years | -29% | -18.4M shares |
| 5 years | -43% | -34M shares |
| Available history | -43% | -35.1M shares |
PRKS has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $126.4M |
| Q1 2026 | $93.8M |
| Q4 2025 | $144.1M |
| Q3 2025 | $7.1M |
| Q2 2025 | $4.6M |
| Q1 2025 | $4.6M |
| Q4 2024 | $37.7M |
PRKS spent $364M buying back its own shares over the past year, about seven times what it spent the year before.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PRKS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.6x | High |
| Q2 2026 | 4.5x | High |
| Q1 2026 | 4.3x | High |
| Q4 2025 | 4.0x | Elevated |
| Q3 2025 | 3.7x | Elevated |
| Q2 2025 | 3.4x | Elevated |
| Q1 2025 | 3.5x | Elevated |
| Q4 2024 | 3.4x | Elevated |
PRKS's net debt is about 4.6 years of its operating earnings (EBITDA), up from 3.7 years a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
PRKS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.3 | Neutral |
| Stochastic | 39.7 | Neutral |
PRKS's weekly RSI is 54 (neutral) and its Stochastic is 40 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
PRKS PE vs Consumer Cyclical Sector
| Metric | PRKS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 18x | 17% below |
| PE % | 73 | 47 | 26 pts above |
PRKS is trading at 15x earnings, a 17% discount to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
PRKS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $34.0 | 18% above |
| 20 week MA | $39.5 | 1.6% above |
| 50 week MA | $37.9 | 5.9% above |
| 100 week MA | $43.1 | 6.8% below |
| 200 week MA | $48.1 | 16% below |
PRKS has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
PRKS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $32.2 | $30.6 | -5.2% |
| 2021 | $30.6 | $66.9 | +119% |
| 2022 | $66.9 | $54.3 | -19% |
| 2023 | $54.3 | $52.8 | -2.7% |
| 2024 | $52.8 | $55.4 | +4.9% |
| 2025 | $55.4 | $36.0 | -35% |
| 2026 YTD | $36.0 | $40.2 | +12% |
PRKS has the edge over LCID on returns for 2026, with the stronger performance.